Research
FORUM TRANSCRIPT

Philips – BiPAP & DreamStation CPAP Class I Recall & Potential Damages – Part 2 – 10 November 2021

  • Public Equity
  • Healthcare
  • North America
PREMIUM

Specialist

Executive at KJC Law Group

Agenda

  • Settlement framework for multi-district litigation and potential damages reimbursement dynamics
  • Case study comparison with Bayer-Monsanto's (ETR: BAYN) Roundup – key similarities and differences
  • Implications of Class I recall on future Philips Respironics (AMS PHIA) (NYSE: PHG) FDA submissions
  • SoClean USD 200m lawsuit against Philips – implications and outlook
  • Potential for Supreme Court escalation

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo